COP28 President Calls On All Countries to Join Global Cooling Pledge in the lead up to COP28

Speaking on the sidelines of the 14th Clean Energy Ministerial, alongside the G20 Energy Transitions Ministerial Meeting, COP28 President Designate Dr. Sultan Al Jaber urged countries to join the global cooling pledge, a partnership between the United Nations Environment Program (UNEP) and the COP28 Presidency, announced earlier in the year. Dr. Al Jaber thanked Dan […]

thaipr.net

24 ก.ค. 66

COP28 and IEA Convene Global Energy Decision Makers to Accelerate a Just, Orderly Energy Transition

The COP28 UAE Presidency and the International Energy Agency (IEA) have convened the first in a landmark series of high-level dialogues through to COP28 around building a 1.5C degree-aligned energy transition. The initiative is being conducted in conjunction with the International Renewable Energy Agency (IRENA) and will be supported by the United Nations Framework Convention on Climate Change (UNFCCC). The dialogues […]

thaipr.net

24 ก.ค. 66

TUMI AND HIGHSNOBIETY JOIN FORCES ON DISRUPTIVE CONTENT SERIES, BRINGING THE TUMI | McLAREN COLLECTION TO THREE FORMULA 1 GRAND PRIX RACES ACROSS THREE CONTINENTS

Captured through the lens of Highsnobiety, this three-part series entitled ‘The High Road‘ will chronicle a journey in McLaren’s supercars through Britain, Singapore, and Las Vegas, and bring to life three unique stories with unexpected talent and eye-catching visuals.  Today, international travel and lifestyle brand TUMI debuted The High Road, a content series created in partnership with Highsnobiety, which will […]

thaipr.net

24 ก.ค. 66

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA

Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML) who may be eligible to receive treatment with Daiichi Sankyo’s VANFLYTA® (quizartinib). The LeukoStrat CDx FLT3 Mutation Assay identifies FLT3-ITD positive AML patients who […]

thaipr.net

21 ก.ค. 66
1 1,342 1,343 1,344 1,345 1,346 3,310